New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
05:59 EDTBLUEbluebird bio announces data from HGB-205 clinical study
bluebird bio on Saturday released initial clinical data from its HGB-205 clinical study of its LentiGlobin BB305 product candidate in beta-thalassemia major subjects. The company said the clinical update provided on two subjects treated in the prior LG001 Study using the prior lentiviral HPV569 product candidate; Subject 3 remains blood transfusion independent 72 months after being transplanted with the lentiviral HPV569 product candidate; Subjects 3 and 4 are producing 2.7 g/dL and 0.4 g/dL of therapeutic beta A-T87Q-globin post-transplant, respectively; No drug product related adverse events were reported in the LG001 Study. The company sees reporting additional data from the HGB-205 Study and from our ongoing Northstar Study in late 2014.
News For BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 3, 2016
10:00 EDTBLUEOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Capella Education (CPLA) initiated with an Outperform at Credit Suisse... DeVry (DV) initiated with an Outperform at Credit Suisse... Gilead (GILD) initiated with a Buy at Standpoint Research... Grand Canyon (LOPE) initiated with a Neutral at Credit Suisse... Hannon Armstrong (HASI) initiated with an Equal Weight at Morgan Stanley... Houghton Mifflin (HMHC) initiated with an Outperform at Credit Suisse... Mediaset (MDIUY) initiated with a Buy at Jefferies... Palo Alto (PANW) initiated with a Buy at Maxim... Splunk (SPLK) initiated with a Buy at Maxim... Strayer (STRA) initiated with a Neutral at Credit Suisse... Tableau (DATA) initiated with a Sell at Maxim... Tesla (TSLA) initiated with a Sell at Berenberg... WisdomTree (WETF) initiated with an Outperform at Northland... bluebird bio (BLUE) initiated with an Outperform at Leerink.
08:02 EDTBLUEbluebird bio initiated with an Outperform at Leerink
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use